Converthera NAD plus Patch
Converthera NAD plus Patch · NICOTINAMIDE ADENINE DINUCLEOTIDE 25 mg/U; GLUTATHIONE 250 mg/U · Patch · Transdermal · Through Medical INC.
NDC 85945-0001-01 · 30 U in 1 PATCH · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Converthera NAD plus Patch (Patch)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Through Medical INC. | NICOTINAMIDE ADENINE DINUCLEOTIDE 25 mg/U; GLUTATHIONE 250 mg/U | Jul 22, 2026 | Jul 29, 2026 |
| Through Medical INC. | GLUTATHIONE 25 mg/U; NICOTINAMIDE ADENINE DINUCLEOTIDE 250 mg/U | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Converthera NAD plus Patch — NDC 85945-0001-01," retrieved September 3, 2026, https://drugdashboards.com/drug/85945000101.
Free to cite with attribution — see how the data is put together.